Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference174 articles.
1. Sistonen J, Fuselli S, Palo JU, Chauhan N, Padh H, Sajantila A . Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales. Pharmacogenet Genomics 2009; 19: 170–179.
2. Clinical Pharmacogenetics Implementation Consortium (CPIC). CYP2C19. Pharmacogenomics Knowledge Database. Available at: https://www.pharmgkb.org/cpic/alleles (accessed 20 March 2014).
3. De Andrés F, Sosa-Macías M, Llerena A . A rapid and simple LC-MS/MS method for the simultaneous evaluation of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 hydroxylation capacity. Bioanalysis 2014; 6: 683–696.
4. Llerena A, Valdivielso MJ, Benítez J, Bertilsson L . Reproducibility over time of mephenytoin and debrisoquine hydroxylation phenotypes. Pharmacol Toxicol 1993; 73: 46–48.
5. CYP2C19 allele nomenclature. Hum. Cytochrome P450 Allele Nomencl. Database. Available at: http://www.cypalleles.ki.se/cyp2c19.htm (accessed 15 May 2014).
Cited by
118 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献